Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register.
Association Between MTHFR Genetic Variants and Multiple Sclerosis in a Southern Iranian Population.
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis.
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Uses of complementary and alternative medicine in multiple sclerosis.
Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy.
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
A Surprisingly Low Prevalence of Demonstrable Stress Urinary Incontinence and Pelvic Organ Prolapse in Women with Multiple Sclerosis Followed at a Tertiary Neurogenic Bladder Clinic.
Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy.
[Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression.]
Ready or not: planning for health declines in couples with advanced multiple sclerosis.
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis.
Pediatric multiple sclerosis: update in diagnosis and management.
Immunomodulatory Effect of Chymotrypsin in CNS Is Sex-independent: Evidence of Anti-inflammatory Role for IL-17 in EAE.
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies.
Pages
« first
‹ previous
…
210
211
212
213
214
215
216
217
218
…
next ›
last »